A photograph of Mark Kessel

Mark Kessel

Mark Kessel is the Chairman of the FIND Board of Directors. He co-founded Symphony Capital LLC, a private equity firm investing in the clinical development programs of biopharmaceutical companies. Kessel was formerly the managing partner of Shearman & Sterling, with day-to-day operating responsibility, and is currently of-counsel to the firm. He is also a member of Fondation Santé and an Editorial Advisor to Nature Biotechnology. He also serves on strategic advisory committees of biotechnology companies. He has served as a director of the Global Alliance for TB Drug Development, the Biotechnology Industry Organization, Organovo Holdings, INC, Dynavax Technologies Corporation, OXiGENE, Inc., Antigenics, Inc., Heller Financial Inc., and Harrods (UK) Limited; as a Trustee of the Museum of the City of New York; and on the advisory committee of the Mount Sinai Rape Crisis Center.

Articles by Mark Kessel

Illustration of the Earth heating up

Opinion: Climate Change Is Dangerous to Your Health

Illustration of man receiving a COVID test.

Opinion: What COVID-19 Has Taught Us About the Importance of Testing

Opinion: Diagnostics for NTDs

Opinion: Diagnostics Needed

The Scientist Placeholder Image

Opinion: A Big Pharma Biotech Fund

Page 1 of 1 - 5 Total Items
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Sex Differences in Neurological Research

Sex Differences in Neurological Research

New Frontiers in Vaccine Development

New Frontiers in Vaccine Development

Products

Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide

Explore a Concise Guide to Optimizing Viral Transduction

A Visual Guide to Lentiviral Gene Delivery

Takara Bio
Inventia Life Science

Inventia Life Science Launches RASTRUM™ Allegro to Revolutionize High-Throughput 3D Cell Culture for Drug Discovery and Disease Research

An illustration of differently shaped viruses.

Detecting Novel Viruses Using a Comprehensive Enrichment Panel

Twist Bio